UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000934
Receipt number R000001121
Scientific Title Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)
Date of disclosure of the study information 2007/12/08
Last modified on 2021/11/15 23:14:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)

Acronym

OGSG 0004

Scientific Title

Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)

Scientific Title:Acronym

OGSG 0004

Region

Japan


Condition

Condition

Patients with unresectable gastric cancer due to limited inavasion or metastasis.

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

TS-1 plus CDDP treatment is evaluated in terms of response rate and adverse events for patients with advanced gastric cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Response Rate(RECIST),
probability on completion

Key secondary outcomes

Overall Survival, Resectability,
Recurrence Mode


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Day1...day8.......day21...day35....day42.......day56
(--TS-1---------).......(---TS-1--------)
CDDP60mg/m2..................CDDP60mg/m2
.....................................2ws rest

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with unresectable advanced gastric cancer due to limited
inavasion or metastasis
2) cP0, CY0, cH0, cM0, and cT4, cN1, or cT2-4, cN2, cM1 (LYM)
*cM1(LYM): distant lymph nodes in the abdomen which can be removed
3) biopsy by endoscopy showed gastric cancer, histologically
4) without prior chemotherapy
5) with measurable metastatic lymph nodes in RECIST criteria
Measurable lesions: lesions larger than 10mm in spiral CT, or
20mm in common CT
6) without liver metastasis and/or peritoneal metastasis by abdominal echo,
CT or laparoscopy.
7) without distant metastasis by blood examination, or chest X-ray,
Without mediastinal lymph node metastasis by chast X-ray
8) age: =>20 and 75=>
9) Performance Status: 0-1 (ECOG criteria)
10) sufficient function of important organs
O WBC: >= 4,000 and =< 12,000/mm3
O Hb >=8.0g/dl
O Platelet: >= 100,000/mm3
O sGOT,sGPT: <100 IU/l
O sT.bil.: <= 1.5 mg/dl
O sCreatinin: <= 1.2mg/dl
O respiratory function: PaO2 in room air >=70 torr
11) written informed consent

Key exclusion criteria

1) Under fresh bleeding from digestive tract
2) Patient who cannot take anticancer medicine orally due to gastrointestinal stenosis.
3) Type 4 gastric cancer
4) history of severe allergy against drug
5) under watery diarrhea
6) with sever disease on important organs (Infection, interstitial
pneumonitis, pulmonary fibrosis, cardiac disease, renal dysfunction, liver dysfunction, DM controlled by insulin)
7) double cancer without carcinoma in citu
8) pregnant women or women who like to be pregnant
9) doctor' s dicision not to be registered to this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasushi Nakane

Organization

Kansai Medical University

Division name

Dpt. surgery

Zip code


Address

10-15 Fumizono-cho Moriguchi-shi 570-8506

TEL

06-6992-1001

Email



Public contact

Name of contact person

1st name
Middle name
Last name Furukawa Hiroshi

Organization

Sakai City Hospital

Division name

Director

Zip code


Address

1-1-1,Minamiyasuicho,Sakai-ku,Sakai, 590-0064

TEL

072-221-1700

Homepage URL


Email



Sponsor or person

Institute

OGSG

Institute

Department

Personal name



Funding Source

Organization

NPO Osaka Chinical Study Supporting Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2002 Year 08 Month 08 Day

Date of IRB


Anticipated trial start date

2002 Year 08 Month 01 Day

Last follow-up date

2008 Year 09 Month 01 Day

Date of closure to data entry

2008 Year 09 Month 01 Day

Date trial data considered complete

2008 Year 09 Month 01 Day

Date analysis concluded

2008 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 12 Month 06 Day

Last modified on

2021 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001121


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name